Regulation & law · 18/10/2004

U.S. Government Makes Provisional Patent Application for Small Molecule Botulinum Toxin Inhibitors Available for Licensing

The U.S. government, represented by the Secretary of the Army, is making the provisional patent application for small molecule inhibitors of botulinum toxin, filed on September 8, 2003, available for licensing under non-exclusive, exclusive, or partially exclusive terms.